Kazia Therapeutics Ltd ADR - ROE
KZIA
Price:
$12
Market Cap:
$27.53M
Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It als...[Read more]
Industry
Biotechnology
IPO Date
1999-01-06
Stock Exchange
NASDAQ
Ticker
KZIA
PE Ratio
[-2.52]
ROE
[-116.86%]
Current Ratio
[2.87]
Dividend Yield
[0%]
Enterprise Value
[-41761101.33]
Dividend History
The ROE as of August 2026 (TTM) for Kazia Therapeutics Ltd ADR (KZIA) is -116.86%
According to Kazia Therapeutics Ltd ADR’s latest financial reports and current stock price. The company's current ROE is -116.86%. This represents a change of -185.43% compared to the average of 136.78% of the last 4 quarters.
Kazia Therapeutics Ltd ADR (KZIA) Historical ROE (quarterly & annually)
How has KZIA ROE performed in the past?
The mean historical ROE of Kazia Therapeutics Ltd ADR over the last ten years is -8.19%. The current -116.86% ROE has changed 1.33% with respect to the historical average. Over the past ten years (40 quarters), KZIA's ROE was at its highest in in the December 2024 quarter at 274.56%. The ROE was at its lowest in in the June 2014 quarter at -292.00%.
Average
-8.19%
Median
-38.83%
Minimum
-169.84%
Maximum
267.33%
Kazia Therapeutics Ltd ADR (KZIA) ROE by Quarter and Year
Discovering the peaks and valleys of Kazia Therapeutics Ltd ADR ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 515.30%
Maximum Annual ROE = 267.33%
Minimum Annual Increase = -257.40%
Minimum Annual ROE = -169.84%
| Year | ROE | Change |
|---|---|---|
| 2025 | 249.39% | -6.71% |
| 2024 | 267.33% | -257.40% |
| 2023 | -169.84% | 24.08% |
| 2022 | -136.88% | 515.30% |
| 2021 | -22.25% | -74.80% |
| 2020 | -88.27% | 22.00% |
| 2019 | -72.35% | 130.53% |
| 2018 | -31.38% | -25.47% |
| 2017 | -42.11% | 18.47% |
| 2016 | -35.55% | 122.43% |
Kazia Therapeutics Ltd ADR (KZIA) Average ROE
How has KZIA ROE performed in the past?
The current ROE of Kazia Therapeutics Ltd ADR (KZIA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
115.63%
5-year avg
37.55%
10-year avg
-8.19%
Kazia Therapeutics Ltd ADR (KZIA) ROE vs. Peers
How is KZIA’s ROE compared to its peers?
Kazia Therapeutics Ltd ADR’s ROE is greater than Can-Fite BioPharma Ltd. (-201.06%), greater than CNS Pharmaceuticals, Inc. (-238.69%), greater than Silo Pharma, Inc. (-88.41%), greater than Soligenix, Inc. (-246.04%), greater than Biodexa Pharmaceuticals Plc (-55.81%), greater than Clearmind Medicine Inc. (-138.23%), greater than InMed Pharmaceuticals Inc. (-72.72%), greater than GRI Bio, Inc. (-199.52%), greater than Oragenics, Inc. (-177.32%), less than Titan Pharmaceuticals, Inc. (1.94%),
| Company | ROE | Market cap |
|---|---|---|
| -201.06% | $1.72M | |
| -238.69% | $3.10M | |
| -88.41% | $5.20M | |
| -246.04% | $5.68M | |
| -55.81% | $1.19M | |
| -138.23% | $2.61M | |
| -72.72% | $2.53M | |
| -199.52% | $137.44K | |
| -177.32% | $2.44M | |
| 1.94% | $3.11M |
Build a custom stock screener for Kazia Therapeutics Ltd ADR (KZIA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kazia Therapeutics Ltd ADR using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kazia Therapeutics Ltd ADR (KZIA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kazia Therapeutics Ltd ADR or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kazia Therapeutics Ltd ADR's ROE?
How is the ROE calculated for Kazia Therapeutics Ltd ADR (KZIA)?
What is the highest ROE for Kazia Therapeutics Ltd ADR (KZIA)?
What is the 3-year average ROE for Kazia Therapeutics Ltd ADR (KZIA)?
What is the 5-year average ROE for Kazia Therapeutics Ltd ADR (KZIA)?
How does the current ROE for Kazia Therapeutics Ltd ADR (KZIA) compare to its historical average?